Cerevance takes in $36 mln
Newly launched neuroscience company Cerevance has raised $36 million in funding. The company's investors are Takeda Pharmaceutical Company Limited and Lightstone Ventures.
5 December 2016•1 min read
Newly launched neuroscience company Cerevance has raised $36 million in funding. The company's investors are Takeda Pharmaceutical Company Limited and Lightstone Ventures.
